Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
NBP holding history
NovaBridge Biosciences in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBP overviewAll 13F holders of NBPFull Q4 2025 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −2,115,277−100.0% | Sold out | Holders |
| Q2 2023 | 2,115,277 | $6.32M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,115,277 | $7.32M | <0.1% | +28,245+1.4% | Added | Holders |
| Q4 2022 | 2,087,032 | $8.72M | <0.1% | +73,830+3.7% | Added | Holders |
| Q3 2022 | 2,013,202 | $8.07M | <0.1% | +55,051+2.8% | Added | Holders |
| Q2 2022 | 1,958,151 | $22.1M | <0.1% | +953,542+94.9% | Added | Holders |
| Q1 2022 | 1,004,609 | $16.3M | <0.1% | +29,729+3.0% | Added | Holders |
| Q4 2021 | 974,880 | $46.2M | <0.1% | +23,506+2.5% | Added | Holders |
| Q3 2021 | 951,374 | $69.0M | <0.1% | +892,026+1,503.0% | Added | Holders |
| Q2 2021 | 59,348 | $4.98M | <0.1% | +59,348 | New | Holders |